{
    "clinical_study": {
        "@rank": "141431", 
        "acronym": "LBP-2", 
        "arm_group": {
            "arm_group_label": "Treatment Continuous Passive Motion", 
            "arm_group_type": "Other", 
            "description": "Single-arm; 3-week treatment plan using Kyrobak compared to baseline (before treatment)"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the efficacy of the Kyrobak continuous passive\n      motion home-use device in relieving low back pain, improving proprioception (balance and\n      fall prevention) and improving the symmetry of muscle function on either side of the spine."
        }, 
        "brief_title": "The Efficacy of the Kyrobak for Chronic Low Back Pain (LBP-2)", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": "Low Back Pain", 
        "condition_browse": {
            "mesh_term": [
                "Back Pain", 
                "Low Back Pain"
            ]
        }, 
        "detailed_description": {
            "textblock": "The Kyrobak is an electrically operated, continuous passive motion device including a\n      platform that performs angular oscillations.  The Kyrobak is used at home as an aid to\n      relieve mild-to-moderate low back pain.\n\n      The study is designed to evaluate the efficacy of daily home use of the Kyrobak for 3 weeks\n      and to assess the sustained efficacy 1 week later.\n\n      The evaluation will include the level of pain using the numerical rating scale (NRS),\n      Digital Posturography, Heart Rate Variability (HRV), Static Surface Electromyography (SEMG),\n      a condition-specific low back pain disability status by the Oswestry Disability Index (ODI)\n      and subject satisfaction."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female, age 18 or older\n\n          -  Level of pain - mild to moderate low back pain (\u22645 NRS pain)\n\n          -  Chronic - symptoms must have been present for at least 12 weeks or more.\n\n          -  Location - lower tip of scapula to back of pelvis\n\n          -  Etiology - non-specific\n\n        Exclusion Criteria:\n\n          -  Patients who have low back pain due to specific and known causes (infection, tumor,\n             osteoporosis, ankylosing spondylitis, fracture, inflammatory process, radicular\n             syndrome (radiating nerve pain from the spine such as sciatica), cauda equinal\n             syndrome (serious neurological disorder where the spinal nerve roots are compressed\n             which can cause).\n\n          -  Weight in excess of 265 lbs. (120.4 kg)\n\n          -  Pregnant or breastfeeding\n\n          -  Recent history of violent trauma\n\n          -  History of previous back surgery\n\n          -  Constant progressive, non-mechanical pain (no relief with bed rest)\n\n          -  Chronic pain other than low back pain\n\n          -  Past medical history of malignant tumor\n\n          -  Has taken an investigational drug within the past 30 days prior to entering the\n             study, or currently enrolled in another investigational study\n\n          -  Mental disorder that would lead to difficulty in questionnaire completion\n\n          -  Any litigation for low back pain\n\n          -  Prolonged use of corticosteroids (i.e. used for 3 months or more)\n\n          -  Present use of prescription pain medication (i.e. Percocet\u00ae, Oxycodone, Vicodin\u00ae,\n             etc.)\n\n          -  Physical disability that prevents the subject to lie down/get up\n\n          -  Drug abuse, immunosuppression, HIV\n\n          -  Any other condition which in the physician's opinion would make it unsafe for the\n             subject to be treated."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "16", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02155283", 
            "org_study_id": "LBP-2"
        }, 
        "intervention": {
            "arm_group_label": "Treatment Continuous Passive Motion", 
            "description": "Daily self-treatments at home for 3 weeks, with up to three 10-minute treatment sessions per day", 
            "intervention_name": "Continuous Passive Motion", 
            "intervention_type": "Device", 
            "other_name": "Kyrobak"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Chronic Low Back Pain", 
            "Mild-to-Moderate Chronic Low Back Pain", 
            "Continuous Passive Motion Devices"
        ], 
        "lastchanged_date": "June 2, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10033"
                }, 
                "name": "New Heights Chiropractic"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "The Kyrobak Continuous Passive Motion Device for the Treatment of Chronic Low Back Pain: A Pilot Study", 
        "other_outcome": {
            "description": "Pain level will be scored by the subject using the NRS on a 0 to 10 scale where 10 represents the highest level of pain and 0 represents no pain.", 
            "measure": "Amount of pain determined by the NRS at the 1-week follow-up after the end of the 3-week treatment plan compared to baseline (before treatment)", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "overall_official": {
            "affiliation": "New Heights Chiropractic", 
            "last_name": "Steven G Geanopulos, DC", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Pain level will be scored by the subject using the NRS on a 0 to 10 scale where 10 represents the highest level of pain and 0 represents no pain.", 
            "measure": "Amount of pain determined by the NRS at the end of the 3-week treatment plan compared to baseline (before treatment)", 
            "safety_issue": "No", 
            "time_frame": "3 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02155283"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Gather information regarding:\nBalance and Fall Prevention using digital posturography", 
                "measure": "Change in proprioception and vestibular function.", 
                "safety_issue": "No", 
                "time_frame": "3 weeks, 4 weeks"
            }, 
            {
                "description": "Functional health status will be determined by the ODI questionnaire completed by the subject (based upon answers from 10 multiple choice questions)", 
                "measure": "Change in functional health status by ODI", 
                "safety_issue": "No", 
                "time_frame": "3 weeks, 4 weeks"
            }, 
            {
                "description": "Gather information regarding:\nSymmetry of muscle function about the spine using static surface electromyography (SEMG)", 
                "measure": "Change in symmetry of muscle function on either side of the spine", 
                "safety_issue": "No", 
                "time_frame": "3 weeks, 4 weeks"
            }, 
            {
                "description": "Gather information regarding:\nAutonomic nervous system activity by measuring heart rate variability (HRV).", 
                "measure": "Change in heart rate variability (and the autonomic system)", 
                "safety_issue": "No", 
                "time_frame": "3 weeks, 4 weeks"
            }
        ], 
        "source": "Radiancy", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Radiancy", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}